Clinical Trial Update: A Study of LY4086940 in Healthy Participants and Participants With Overweight or Obesity, With or Without Type 2 Diabetes [Phase 1]

View source ↗

Summary

Phase 1 study of LY4086940 in healthy volunteers and participants with overweight or obesity, with or without type 2 diabetes, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Type 2 Diabetes Mellitus

Drugs mentioned

• LY4086940

Snippet

Sponsor: Eli Lilly and Company | Conditions: Healthy, Overweight | Phase 1 | Status: RECRUITING